Hire Machine Learning Companies to Work with

The biggest challenge facing B2B marketers is connecting their activities to revenue. There are just too many touch points and people involved in buying decisions - which span months - to accurately make that connection. We know this because we’ve been there! In their previous jobs, our founders needed a revenue attribution solution designed specifically for B2B. They couldn’t find one. So they built the solution themselves. Enter Dreamdata, the B2B revenue attribution platform for small to midsize B2B companies seeking to stop the guesswork and build, repeat, and scale success. We pull together all relevant data by introducing a smart on-site behavioural tracking script and integrating all relevant commercial data from CRM, Ads, Automations, and Customer Success tools. The algorithms in our out-of-the-box, no-code platform join, clean and sort all this data before transforming it into easy-to-digest, actionable insights. This enables B2B growth leaders to: - Build complete B2B customer journeys and gain unprecedented insight into every touch of every customer journey; from anonymous visitor to paying customer. - Find value through revenue attribution; revealing the revenue-generating performance of activities across the pipeline, channels and campaigns. - Benchmark growth and predict revenue through accurate and interactive reporting on all marketing, sales, and customer success activities. - Aggressively build and scale what works by deep diving into every aspect of every channel, campaign and experiment to rapidly drive up ROI. With Dreamdata’s insights, B2B marketing and sales align like never before. Every touch of every deal is disclosed. Meaning you will finally take control of all your revenue activities in one place.

“We value taking ownership and setting ourselves ambitious goals while staying genuine and delighting customers.” We are Amberscript, a dynamic startup with the goal of making audio accessible by transforming it into text. With the best speech-recognition algorithms on the market, we save our customers hundreds of thousands of hours of manual labor and we enable thousands of people with auditory impairments (deaf and hard of hearing) to understand video and audio more easily. We are in the process of disrupting a very traditional market (transcription & subtitling). Now that we have achieved product-market fit, we are scaling rapidly. Our AI speech-to-text engine obtains the best results in the market, as proven by independent tests in the media. Our product is being used by 1.5 million+ users worldwide.

BenevolentAI (AMS: BAI) is a leading, clinical-stage AI-enabled drug discovery and development company listed on the Euronext Amsterdam stock exchange. Through the combined capabilities of its AI platform, scientific expertise, and wet-lab facilities, BenevolentAI is well-positioned to deliver novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform™ powers a growing in-house pipeline of 13 named drug programmes and over 10 exploratory programmes, and it maintains successful collaborations with AstraZeneca, as well as leading research and charitable institutions. BenevolentAI is headquartered in London, with a research facility in Cambridge (UK) and a further office in New York. *Reach out to us* Email: hello@benevolent.ai Careers: Careers@benevolent.ai Twitter: @benevolent_ai Website: benevolent.com

Luminance is the world’s most advanced AI technology for the legal processing of contracts and documents. Founded by mathematicians from the University of Cambridge, Luminance’s AI reads and forms a conceptual understanding of documents in any language. Luminance uses this understanding to augment the spectrum of legal matters, from AI-powered contract drafting, negotiation and review to investigations and eDiscovery. Luminance is used by over 500 customers in 60 countries, including all of the Big Four consultancy firms, a quarter of the world’s largest law firms and multinational organisations such as Tesco and Ferrero. Luminance is the proud recipient of a number of prestigious accolades including the Queen’s Award for Innovation, Tech Nation’s 'Future Fifty' programme and CNBC’s ‘Upstart 100’ list, as well as being named a Tech Pioneer by the World Economic Forum.

To make a real impact on your viewer engagement you need AI technology to understand your content. Amsterdam-based Media Distillery is an acknowledged leader in AI-driven video analysis technology for the worldwide entertainment Industry. The cloud-based Deep Content Understanding™ solution provides fully automated real-time content analysis which empowers broadcasters and pay-TV service providers to optimise viewer engagement through accelerated and accurate content discovery and enhanced user experience. Media Distillery’s customer base includes major operators and broadcasters located around the globe including Telenet, NOS, VTR Chile and YouSee, delivering enriched viewing experiences to over 30 million viewers.

Metamaze is an AI-driven Intelligent Document Processing SaaS platform that enables companies to automatically process, extract and structure information from any type of document. The Metamaze Intelligent Document Processing (IDP) platform allows you to train, manage, integrate and use state-of-the-art A.I. models for extracting information from and automatically processing documents in a user friendly way. At Metamaze we believe in the extraordinary value of people. All too often, human capital within organisations remains unused and underestimated. Billions of USD are still being spent yearly on manual data entry, restructuring, and validation. People should no longer be occupied with mind-numbing, boring and non-value adding activities. We believe the world can be a better, safer and more effective place when every resource is exploiting their strengths to the maximum. As of 2021, it is no longer acceptable that these precious and irreplaceable gifts are squandered by sub-optimal allocation of resources.